Form 4: Agilent Director Sue Rataj Receives Stock Award

Agilent Technologies Director Sue H. Rataj acquired 2,158 shares of common stock valued at $241,195.50 as part of a compensation award.

Summary

• Agilent Technologies, Inc. Director Sue H. Rataj acquired 2,158 shares of common stock on March 19, 2026.
• The shares were acquired at a price of $111.75 per share, totaling $241,195.50.
• This acquisition was an award of Agilent Technologies, Inc. common stock for Non-Employee Directors, fully vested upon grant.
• Following this transaction, Ms. Rataj beneficially owns 23,617 shares of Agilent common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event. While it's a compensation award rather than a discretionary purchase, it increases director ownership, aligning interests with shareholders, which is generally favorable.

Positives

• The acquisition of 2,158 shares by a director aligns management's interests with those of shareholders.
• The shares were fully vested upon grant, indicating immediate ownership for the director.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• "Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant."

Industry Context

StockSavvy.ai notes that Form 4 filings primarily report insider transactions and do not typically provide broader industry context or analysis. This transaction reflects standard director compensation practices within the life sciences and diagnostics tools industry, where equity awards are common to align director interests with long-term company performance.

Comparison to Industry Standards

• StockSavvy.ai observes that equity compensation for non-employee directors, such as this stock award, is a common practice across publicly traded companies, including those in the life sciences and diagnostics sector like Thermo Fisher Scientific, Danaher Corporation, and PerkinElmer. The specific value and number of shares awarded are typically determined by the company's compensation committee based on market benchmarks for director compensation and the company's performance, though this filing does not provide those comparative details.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Director Sue H. Rataj is a related party transaction, as it involves an insider receiving equity compensation from the company.

Stakeholder Impact

• Shareholders: Increased director ownership may be seen as a positive signal of alignment between management and shareholder interests.
• Employees: No direct impact mentioned in this filing.
• Customers: No direct impact mentioned in this filing.
• Suppliers: No direct impact mentioned in this filing.
• Creditors: No direct impact mentioned in this filing.

Key Dates

Recommendation

While the director's acquisition of shares is a positive signal of alignment, it is an equity award as part of compensation rather than an open market purchase. This type of transaction typically does not warrant a strong 'buy' signal on its own, but it reinforces a 'hold' position given the director's continued vested interest in the company's performance.

Keywords

Agilent Technologies, A, Form 4, Insider Transaction, Stock Award, Director Compensation, Equity Grant, SEC Filing